The Federal Government's 2015-16 Budget announcements benefit research
The Federal Government’s 2015-16 Budget was announced this week with a boost for medical research funding. The new funding is expected to save lives and help thousands of Australians, especially those living with melanoma. Hopefully this will ensure more government support over the next few years for MIA research.
The Government will distribute more than $400 million from the Medical Research Future Fund (MRFF) for health and medical research over the next four years, beginning with an initial disbursement of $10 million in 2015-16.
The MRFF fund has come at the best time to deliver renewed confidence to the health and medical research sector. Within a decade there will be a doubling of funding for medical research via a safe-guarded future fund while giving some immediate relief through an initial $10 million disbursement, and another $407 million to come.
“With an ageing population and more than seven million Australians already living with chronic illnesses such as cardiovascular disease, cancer and mental health issues, we cannot afford not to invest in health and medical research to find new ways to diagnose, treat and prevent these debilitating diseases,” said Association of Australian Medical Research Institutes (AAMRI) President, Professor Doug Hilton.
Professor Hilton said that health and medical research supported by the MRFF would not only improve life expectancy and quality of life for Australians, it would also deliver financial returns to the nation.
“Every dollar invested in health and medical research generates more than two dollars in health and productivity gains by reducing the burden of disease on the health system and productivity, and through the creation of new innovative businesses and jobs in the health industry,” he said.
We are extremely grateful for our community fundraisers, who, even in this difficult time, have given up their time and effort to fundraise so we can continue to work towards our goal of zero deaths from melanoma.
Melanoma patients are set to benefit from subsidised access to immunotherapy treatment for high risk early-stage and advanced-stage melanoma patients.
An informative article on how immunotherapy is revolutionising cancer treatment, written by Jill Margo and featured in the Australian Financial Review.
Melanoma patients and their families in the Riverina will benefit from strengthened and sustained melanoma services with the merger of the Amie St Clair Melanoma Trust and Melanoma Institute Australia.
Belmont High School at Lake Macquarie has been announced winner of the 2019 SunSafe Student Ambassador Program video competition.
It’s time again to say thank you to our amazing community fundraisers!
Videos of the sessions at the recent Patient Information Evening co-hosted by Melanoma Institute Australia (MIA) and Melanoma Patients Australia (MPA) are now available for viewing.
MIA is well-represented in the poster sessions at the Society for Melanoma Research 2019 Congress in the USA, with four poster presentations being given by members of our translational research lab.
Professor Georgina Long has today opened the Society for Melanoma Research 2019 Congress in Salt Lake City, Utah.
MIA’s Co-Medical Directors, Professor Georgina Long and Professor Richard Scolyer, have both been named Highly Cited Researchers, according to the Clarivate Analytics Highly Cited Researchers 2019 list.
Melanoma Patients Australia (MPA) and Melanoma Institute Australia (MIA) have announced a new multi-year agreement to provide enhanced support services for melanoma patients nationally.
It is time again to say thank you to our incredible community fundraisers who are helping us get closer to our goal of zero deaths from melanoma.
MIA has presented promising data regarding progression-free survival rates for advanced melanoma patients at the ESMO 2019 Congress in Barcelona.
Another month has flown by and yet again we have a host of amazing community fundraisers who generously gave up their time to help us reach our goal of zero deaths from melanoma.
Comments in favour of giving patients with BRAF-positive melanoma access to first-line immunotherapy need to be submitted online prior to October 9, 2019.
Jay's Longest Melanoma March documentary is screening this Sunday 22 September at 1pm (AEST) on Channel 10, capturing behind the scenes of the 2000km walk, Adelaide to Sydney in 50 days. Uniting to end melanoma.
It’s been a month since we highlighted some of our incredibly generous community fundraisers. We thought we’d have a look back at August and put the spotlight on more of the wonderful people who give up their time to fundraise for MIA, so we can continue to edge closer to our goal of zero deaths from melanoma.
They are a formidable team - in work and in play